Growth Metrics

Exagen (XGN) Equity Ratio (2018 - 2025)

Exagen's Equity Ratio history spans 8 years, with the latest figure at 0.3 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 40.87% year-over-year to 0.3; the TTM value through Dec 2025 reached 0.3, up 40.87%, while the annual FY2025 figure was 0.3, 40.87% up from the prior year.
  • Equity Ratio reached 0.3 in Q4 2025 per XGN's latest filing, up from 0.29 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.74 in Q1 2021 to a low of 0.16 in Q1 2025.
  • Average Equity Ratio over 5 years is 0.46, with a median of 0.45 recorded in 2023.
  • The largest YoY upside for Equity Ratio was 40.87% in 2025 against a maximum downside of 59.61% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.69 in 2021, then fell by 28.43% to 0.49 in 2022, then fell by 19.07% to 0.4 in 2023, then tumbled by 46.43% to 0.21 in 2024, then surged by 40.87% to 0.3 in 2025.
  • Per Business Quant, the three most recent readings for XGN's Equity Ratio are 0.3 (Q4 2025), 0.29 (Q3 2025), and 0.36 (Q2 2025).